Form 8-K - Current report:
SEC Accession No. 0000950170-24-022068
Filing Date
2024-02-28
Accepted
2024-02-28 16:09:24
Documents
15
Period of Report
2024-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20240228.htm   iXBRL 8-K 42658
2 EX-99.1 crnx-ex99_1.htm EX-99.1 127844
3 GRAPHIC img113038668_0.jpg GRAPHIC 6091
4 GRAPHIC img113038668_1.jpg GRAPHIC 6091
  Complete submission text file 0000950170-24-022068.txt   309096

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20240228.xsd EX-101.SCH 23892
16 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20240228_htm.xml XML 4534
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 24695396
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)